CytoDyn
(OTC) CYDY
CytoDyn Financials at a Glance
Market Cap
$373.51M
Revenue (TTM)
$5.92M
Net Income (TTM)
$38.79M
EPS (TTM)
$-0.03
P/E Ratio
-9.18
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.29
Volume
1,668,225
Open
$0.29
Price
$0.29
Volume
1,668,225
Open
$0.29
Previous Close
$0.29
Daily Range
$0.29 - $0.30
52-Week Range
$0.20 - $0.45
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.29
Volume
1,668,225
Open
$0.29
Previous Close
$0.29
Daily Range
$0.29 - $0.30
52-Week Range
$0.20 - $0.45
CYDY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CytoDyn
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Jacob P. Lalezari, MD
Website
www.cytodyn.comHeadquarters
Vancouver, WA 98660, US
CYDY Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
2%
Net Income Margin
7%
Return on Equity
0%
Return on Capital
46%
Return on Assets
-2%
Earnings Yield
-10.89%
Dividend Yield
0.00%
Payout Ratio
-2.85%
Stock Overview
Market Cap
$373.51M
Shares Outstanding
1.27B
Volume
1.67M
Short Interest
0.00%
Avg. Volume
1.58M
Financials (TTM)
Gross Profit
$18.00K
Operating Income
$11.32M
EBITDA
$8.62M
Operating Cash Flow
$8.77M
Capital Expenditure
$0.00
Free Cash Flow
$8.77M
Cash & ST Invst.
$11.90M
Total Debt
$27.34M
CytoDyn Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$373.51M
N/A
Market Cap/Employee
$41.50M
N/A
Employees
9
N/A
Net Income
$4.69M
+1.4%
EBITDA
$0.00
+100.0%
Quarterly Fundamentals
Net Cash
$24.88M
-127.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$28.79M
+84561.8%
Short Term Debt
$11.75M
-56.9%
Return on Assets
-2.10%
N/A
Return on Invested Capital
46.15%
N/A
Free Cash Flow
$5.52M
-11.4%
Operating Cash Flow
$5.52M
-11.4%